Cargando…

A new device for measurement of fibrin clot lysis: application to the Euglobulin Clot Lysis Time

BACKGROUND: Determination of clot lysis times on whole blood, diluted whole blood, plasma or plasma fraction has been used for many years to assess the overall activity of the fibrinolytic system. We designed a completely computerised semi-automatic 8-channel device for measurement and determination...

Descripción completa

Detalles Bibliográficos
Autores principales: Boudjeltia, K Zouaoui, Cauchie, Ph, Remacle, Cl, Guillaume, M, Brohée, D, Hubert, JL, Vanhaeverbeek, M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2002
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC113256/
https://www.ncbi.nlm.nih.gov/pubmed/11985782
http://dx.doi.org/10.1186/1472-6750-2-8
_version_ 1782120233361735680
author Boudjeltia, K Zouaoui
Cauchie, Ph
Remacle, Cl
Guillaume, M
Brohée, D
Hubert, JL
Vanhaeverbeek, M
author_facet Boudjeltia, K Zouaoui
Cauchie, Ph
Remacle, Cl
Guillaume, M
Brohée, D
Hubert, JL
Vanhaeverbeek, M
author_sort Boudjeltia, K Zouaoui
collection PubMed
description BACKGROUND: Determination of clot lysis times on whole blood, diluted whole blood, plasma or plasma fraction has been used for many years to assess the overall activity of the fibrinolytic system. We designed a completely computerised semi-automatic 8-channel device for measurement and determination of fibrin clot lysis. The lysis time is evaluated by a mathematical analysis of the lysis curve and the results are expressed in minute (range: 5 to 9999). We have used this new device for Euglobulin Clot Lysis Time (ECLT) determination, which is the most common test used in laboratories to estimate plasma fibrinolytic capacity. RESULTS: The correlation between ECLT and manual method is very tight : R = 0,99; p < 10(-6). The efficiency scores of the method are <4% in intra-assay and <7% in inter-assay. It allows to achieve the tests on hyperlipaemic samples. This new device has been easily integrated in laboratory routine and allows to achieve several ECLT every day without disturbance of laboratory workflow. CONCLUSIONS: The routine use of this new device could be useful in various situations such as assessment in atherosclerosis and arteriosclerosis associated diseases, coagulation survey of liver transplantations, cardiovascular surgery or pharmacological research. It has already provided highly promising results in preliminary studies on the relation between fibrinolysis and cardiovascular risk factors.
format Text
id pubmed-113256
institution National Center for Biotechnology Information
language English
publishDate 2002
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-1132562002-05-23 A new device for measurement of fibrin clot lysis: application to the Euglobulin Clot Lysis Time Boudjeltia, K Zouaoui Cauchie, Ph Remacle, Cl Guillaume, M Brohée, D Hubert, JL Vanhaeverbeek, M BMC Biotechnol Methodology Article BACKGROUND: Determination of clot lysis times on whole blood, diluted whole blood, plasma or plasma fraction has been used for many years to assess the overall activity of the fibrinolytic system. We designed a completely computerised semi-automatic 8-channel device for measurement and determination of fibrin clot lysis. The lysis time is evaluated by a mathematical analysis of the lysis curve and the results are expressed in minute (range: 5 to 9999). We have used this new device for Euglobulin Clot Lysis Time (ECLT) determination, which is the most common test used in laboratories to estimate plasma fibrinolytic capacity. RESULTS: The correlation between ECLT and manual method is very tight : R = 0,99; p < 10(-6). The efficiency scores of the method are <4% in intra-assay and <7% in inter-assay. It allows to achieve the tests on hyperlipaemic samples. This new device has been easily integrated in laboratory routine and allows to achieve several ECLT every day without disturbance of laboratory workflow. CONCLUSIONS: The routine use of this new device could be useful in various situations such as assessment in atherosclerosis and arteriosclerosis associated diseases, coagulation survey of liver transplantations, cardiovascular surgery or pharmacological research. It has already provided highly promising results in preliminary studies on the relation between fibrinolysis and cardiovascular risk factors. BioMed Central 2002-05-02 /pmc/articles/PMC113256/ /pubmed/11985782 http://dx.doi.org/10.1186/1472-6750-2-8 Text en Copyright © 2002 Boudjeltia et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.
spellingShingle Methodology Article
Boudjeltia, K Zouaoui
Cauchie, Ph
Remacle, Cl
Guillaume, M
Brohée, D
Hubert, JL
Vanhaeverbeek, M
A new device for measurement of fibrin clot lysis: application to the Euglobulin Clot Lysis Time
title A new device for measurement of fibrin clot lysis: application to the Euglobulin Clot Lysis Time
title_full A new device for measurement of fibrin clot lysis: application to the Euglobulin Clot Lysis Time
title_fullStr A new device for measurement of fibrin clot lysis: application to the Euglobulin Clot Lysis Time
title_full_unstemmed A new device for measurement of fibrin clot lysis: application to the Euglobulin Clot Lysis Time
title_short A new device for measurement of fibrin clot lysis: application to the Euglobulin Clot Lysis Time
title_sort new device for measurement of fibrin clot lysis: application to the euglobulin clot lysis time
topic Methodology Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC113256/
https://www.ncbi.nlm.nih.gov/pubmed/11985782
http://dx.doi.org/10.1186/1472-6750-2-8
work_keys_str_mv AT boudjeltiakzouaoui anewdeviceformeasurementoffibrinclotlysisapplicationtotheeuglobulinclotlysistime
AT cauchieph anewdeviceformeasurementoffibrinclotlysisapplicationtotheeuglobulinclotlysistime
AT remaclecl anewdeviceformeasurementoffibrinclotlysisapplicationtotheeuglobulinclotlysistime
AT guillaumem anewdeviceformeasurementoffibrinclotlysisapplicationtotheeuglobulinclotlysistime
AT broheed anewdeviceformeasurementoffibrinclotlysisapplicationtotheeuglobulinclotlysistime
AT hubertjl anewdeviceformeasurementoffibrinclotlysisapplicationtotheeuglobulinclotlysistime
AT vanhaeverbeekm anewdeviceformeasurementoffibrinclotlysisapplicationtotheeuglobulinclotlysistime
AT boudjeltiakzouaoui newdeviceformeasurementoffibrinclotlysisapplicationtotheeuglobulinclotlysistime
AT cauchieph newdeviceformeasurementoffibrinclotlysisapplicationtotheeuglobulinclotlysistime
AT remaclecl newdeviceformeasurementoffibrinclotlysisapplicationtotheeuglobulinclotlysistime
AT guillaumem newdeviceformeasurementoffibrinclotlysisapplicationtotheeuglobulinclotlysistime
AT broheed newdeviceformeasurementoffibrinclotlysisapplicationtotheeuglobulinclotlysistime
AT hubertjl newdeviceformeasurementoffibrinclotlysisapplicationtotheeuglobulinclotlysistime
AT vanhaeverbeekm newdeviceformeasurementoffibrinclotlysisapplicationtotheeuglobulinclotlysistime